GlassScriptPhysician profile
Diana Herrera
NPI 1366897167
$1,184.06
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.30 · 2021: $257 · 2022: $496 · 2023: $265 · 2024: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $384.31 | 2021-2023 | |
| Baxter Healthcare | $191.80 | 2023-2024 | Perclot |
| Dysis Medical, INC. | $132.93 | 2023 | Dysis V3 Digital Coploscope, Dysis Ultra 2.0, Dysis View |
| Medtronic, INC. | $98.66 | 2022 | |
| Evofem Biosciences, INC. | $88.91 | 2021-2022 | |
| Agile Therapeutics, INC. | $29.89 | 2021-2023 | Twirla |
| Coopersurgical, INC. | $28.59 | 2021 | |
| Scynexis, INC. | $25.75 | 2022 | |
| Exeltis, USA INC. | $23.43 | 2022 | |
| Medicem INC. | $21.14 | 2021 | |
| Millicent US INC | $20.93 | 2024 | Femring, Intrarosa |
| Hologic Sales and Service, LLC | $18.19 | 2021 | |
| Amgen INC. | $18.13 | 2022 | |
| Pfizer INC. | $17.04 | 2024 | |
| Northgate Technologies, INC. | $15.51 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.88 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.